Publications by authors named "Chih-Lin Lin"

Claim this Profile
A
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C.
Chun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, Tai-Chung Tseng, Chen-Hua Liu, Chun-Yen Lin, Han-Chieh Lin, Chih-Lin Lin

J Formos Med Assoc· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Sofosbuvir/Velpatasvir Therapy on Extrahepatic Manifestations in Patients With Type 2 Diabetes and Chronic Hepatitis C: Insights From a Nationwide Hepatitis C Virus Registry in Taiwan.
Szu-Jen Wang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chien-Wei Huang, Chih-Lang Lin, Chih-Lin Lin, Han-Chieh Lin

Kaohsiung J Med Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseases.
Tai-Chung Tseng, Yao-Chun Hsu, Tung-Hung Su, Chen-Hua Liu, Chia-Chi Wang, Chih-Lin Lin

J Formos Med Assoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Yun-Chu Chen, Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, Wei-Yu Kao, Chih-Lin Lin

J Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global strategies and actions to eliminate hepatitis B virus infection.
Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tenofovir entecavir treatment on progression of chronic hepatitis B: A nationwide cohort study.
Wan-Jung Wu, Wen-Jie Liu, Chih-Lin Lin, Chun-Jen Liu, Yi-Wen Huang

JHEP Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry.
Tyng-Yuan Jang, Chung-Feng Huang, Te-Sheng Chang, Chun-Chi Yang, Ching-Chu Lo, Chih-Lang Lin, Chih-Lin Lin, Han-Chieh Lin

J Formos Med Assoc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral-Induced Cure of Hepatitis C Virus Infection.
Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, Wei-Yu Kao, Chih-Lin Lin

Aliment Pharmacol Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection.
Chen-Hua Liu, Pin-Nan Cheng, Yu-Jen Fang, Chi-Yi Chen, Wei-Yu Kao, Chih-Lin Lin

J Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and safety of universal 8-week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan.
Szu-Jen Wang, Chung-Feng Huang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chih-Lang Lin, Chih-Lin Lin, Han-Chieh Lin

Kaohsiung J Med Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients: Findings from the Taiwan hepatitis C registry program.
Hung-Wei Wang, Yu-Syuan Zeng, Chung-Feng Huang, Chi-Yi Chen, Hsing-Tao Kuo, Chun-Yen Lin, Chih-Lang Lin, Han-Chieh Lin, Chih-Wen Lin, Chih-Lin Lin

J Formos Med Assoc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age at HBsAg seroclearance on hepatic outcomes and life expectancy in men with chronic HBV infection based on multi-state modeling of the natural history.
Wen-Jie Liu, Wan-Jung Wu, Chih-Lin Lin, Chun-Jen Liu, Yi-Wen Huang

J Gastroenterol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.
Chin-Wei Chang, Wei-Fan Hsu, Kuo-Chih Tseng, Chi-Yi Chen, Pin-Nan Cheng, Chun-Yen Lin, Chih-Lang Lin, Chih-Lin Lin, Chih-Wen Lin, Han-Chieh Lin

Dig Dis Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29-year follow-up.
Ming-Whei Yu, Wan-Jung Wu, Chih-Lin Lin, Chun-Jen Liu, Wei-Ya Peng

Hepatol Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antivirals.
Chen-Hua Liu, Yu-Ping Chang, Yu-Jen Fang, Pin-Nan Cheng, Chi-Yi Chen, Chih-Lin Lin

J Gastroenterol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan.
Chun-Chi Yang, Chung-Feng Huang, Te-Sheng Chang, Ching-Chu Lo, Chao-Hung Hung, Chih-Lang Lin, Chih-Lin Lin, Han-Chieh Lin

Infect Dis Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should we expand treatment initiation criteria for chronic HBV infection: Pros.
Chih-Lin Lin, Jia-Horng Kao

Clin Liver Dis (Hoboken)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
Chen-Hua Liu, Yu-Ping Chang, Ji-Yuh Lee, Chi-Yi Chen, Wei-Yu Kao, Chih-Lin Lin

J Med Virol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan.
Ming-Lung Yu, Chi-Ming Tai, Lein-Ray Mo, Hsing-Tao Kuo, Chung-Feng Huang, Chien-Lin Chen, Chih-Lang Lin, Ta-Ya Lin, Chih-Lin Lin, Han-Chieh Lin

Hepatol Int· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases.
Pin-Nan Cheng, Wen-Jone Chen, Charles Jia-Yin Hou, Chih-Lin Lin, Ming-Ling Chang, Chun-Yen Lin, Han-Chieh Lin, Tsung-Hsien Lin

Clin Mol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program.
Ming-Ying Lu, Chung-Feng Huang, Chao-Hung Hung, Chi-Ming Tai, Lein-Ray Mo, Chien-Lin Chen, Chih-Lang Lin, Ta-Ya Lin, Chih-Lin Lin, Han-Chieh Lin

Clin Mol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime risk of liver-related outcomes and determinants in male inactive carriers of chronic hepatitis B.
Wan-Jung Wu, Chih-Lin Lin, Chun-Jen Liu, Yi-Wen Huang, Jui-Ting Hu

J Med Virol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection.
Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry.
Te-Sheng Chang, Chung-Feng Huang, Hsing-Tao Kuo, Ching-Chu Lo, Chien-Wei Huang, Chih-Lang Lin, Chih-Lin Lin, Han-Chieh Lin

Hepatol Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute cytomegalovirus hepatitis in an immunocompetent patient: A case report.
Jack P Wang, Bou-Zenn Lin, Chih-Lin Lin, Kuan-Yang Chen, Tsung-Jung Lin

World J Clin Cases· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis